These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 34980106)
1. Novel deletion of exon 3 in TYR gene causing Oculocutaneous albinism 1B in an Indian family along with intellectual disability associated with chromosomal copy number variations. Dhangar S; Panchal P; Ghatanatti J; Suralkar J; Shah A; Vundinti BR BMC Med Genomics; 2022 Jan; 15(1):2. PubMed ID: 34980106 [TBL] [Abstract][Full Text] [Related]
2. Genetic studies of multiple consanguineous Pakistani families segregating oculocutaneous albinism identified novel and reported mutations. Gul H; Shah AH; Harripaul R; Mikhailov A; Prajapati K; Khan E; Ullah F; Zubair M; Ali MZ; Shah AH; Salman S; Khan S; Vincent JB; Khan MA Ann Hum Genet; 2019 Jul; 83(4):278-284. PubMed ID: 30868578 [TBL] [Abstract][Full Text] [Related]
3. Identification of a Homozygous Missense Mutation in the TYR Gene in a Chinese Family with OCA1. Wang Y; Zhou YF; Shen N; Zhu YW; Tan K; Wang X Curr Med Sci; 2018 Oct; 38(5):932-936. PubMed ID: 30341532 [TBL] [Abstract][Full Text] [Related]
4. TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestations. Chen C; Li J; Wang B; Wang Y; Yu X Exp Eye Res; 2024 Feb; 239():109761. PubMed ID: 38145795 [TBL] [Abstract][Full Text] [Related]
5. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism. Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599 [TBL] [Abstract][Full Text] [Related]
6. Identifying genetic defects in oculocutaneous albinism patients of West Bengal, Eastern India. Dutta T; Ganguly K; Saha A; Sil A; Ray K; Sengupta M Mol Biol Rep; 2024 Jul; 51(1):818. PubMed ID: 39014059 [TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of a Chinese family with oculocutaneous albinism. Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221 [TBL] [Abstract][Full Text] [Related]
8. Identification of TYR mutations in patients with oculocutaneous albinism. Sun W; Shen Y; Shan S; Han L; Li Y; Zhou Z; Zhong Z; Chen J Mol Med Rep; 2018 Jun; 17(6):8409-8413. PubMed ID: 29658579 [TBL] [Abstract][Full Text] [Related]
9. Identification of a functionally significant tri-allelic genotype in the Tyrosinase gene (TYR) causing hypomorphic oculocutaneous albinism (OCA1B). Norman CS; O'Gorman L; Gibson J; Pengelly RJ; Baralle D; Ratnayaka JA; Griffiths H; Rose-Zerilli M; Ranger M; Bunyan D; Lee H; Page R; Newall T; Shawkat F; Mattocks C; Ward D; Ennis S; Self JE Sci Rep; 2017 Jun; 7(1):4415. PubMed ID: 28667292 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the compound heterozygous variants of TYR gene in a northern Chinese family with Oculocutaneous albinism type 1. Si S; Jia X; Xu L; Qin Q; Wu J; Ji W; Dong K; Zhang X; Cao L; Wang H; Liu P; Wang R; Bai J; Fu S; Huang Y; Sun W Pigment Cell Melanoma Res; 2023 Nov; 36(6):472-480. PubMed ID: 37403904 [TBL] [Abstract][Full Text] [Related]
12. SLC45A2 mutation frequency in Oculocutaneous Albinism Italian patients doesn't differ from other European studies. Mauri L; Barone L; Al Oum M; Del Longo A; Piozzi E; Manfredini E; Stanzial F; Benedicenti F; Penco S; Patrosso MC Gene; 2014 Jan; 533(1):398-402. PubMed ID: 24096233 [TBL] [Abstract][Full Text] [Related]
13. SLC45A2 variations in Indian oculocutaneous albinism patients. Sengupta M; Chaki M; Arti N; Ray K Mol Vis; 2007 Aug; 13():1406-11. PubMed ID: 17768386 [TBL] [Abstract][Full Text] [Related]
14. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene. Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053 [TBL] [Abstract][Full Text] [Related]
15. Delineating Novel and Known Pathogenic Variants in Shakil M; Akbar A; Aisha NM; Hussain I; Ullah MI; Atif M; Kaul H; Amar A; Latif MZ; Qureshi MA; Mahmood S Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328057 [TBL] [Abstract][Full Text] [Related]
16. Novel compound heterozygous mutations in OCA2 gene associated with non-syndromic oculocutaneous albinism in a Chinese Han patient: a case report. Wang H; Wan Y; Yang Y; Li H; Mao L; Gao S; Xu J; Wang J BMC Med Genet; 2019 Jul; 20(1):130. PubMed ID: 31345173 [TBL] [Abstract][Full Text] [Related]
17. Ophthalmo-genetic analysis of Pakistani patients with nonsyndromic oculocutaneous albinism through whole exome sequencing. Gul H; Ali MZ; Khan E; Zubair M; Badar M; Khan S; Shah AH; Khan MA J Pak Med Assoc; 2017 May; 67(5):790-792. PubMed ID: 28507374 [TBL] [Abstract][Full Text] [Related]
19. Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism. Jiang B; Zhang H; Kan Y; Gao X; Du Z; Liu Q Mol Genet Genomic Med; 2024 Jan; 12(1):e2297. PubMed ID: 37882226 [TBL] [Abstract][Full Text] [Related]
20. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations. Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G Mol Vis; 2015; 21():730-5. PubMed ID: 26167114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]